Myeloma Studies
Dean Oncology is currently conducting 2 Myeloma studies.
Mulitple Myeloma (Study E1A05)
Phase 3 Study for patients with multiple myeloma who’ve completed a dexamethasone-based induction regimen.
Myeloma (Study E1A06)
Phase 3 Study in newly diagnosed myeloma patients who are not candidates for high-dose therapy.
For more information about a study contact Susie at 608-410-2724. Please refer to study number when calling.